Dynamic Technology Lab Private LTD Cytom X Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$6.33 - $9.91 $132,790 - $207,891	-20,978 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$6.6 - $9.0 $138,454 - $188,802	20,978 New	20,978 $162,000
Q4 2020 Feb 11, 2021	SELL	$6.47 - $7.9 $114,260 - $139,514	-17,660 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$6.55 - $8.83 $42,260 - $56,971	6,452 Added 57.57%	17,660 $117,000
Q2 2020 Aug 14, 2020	BUY	$7.4 - $14.64 $82,939 - $164,085	11,208 New	11,208 $93,000
Q4 2019 Feb 14, 2020	SELL	$5.17 - $8.91 $124,069 - $213,822	-23,998 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.38 - $12.25 $177,105 - $293,975	23,998 New	23,998 $177,000
Q2 2018 Aug 14, 2018	SELL	$21.38 - $29.68 $367,265 - $509,843	-17,178 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$21.76 - $34.22 $373,793 - $587,831	17,178 New	17,178 $488,000
Q4 2017 Feb 09, 2018	SELL	$19.0 - $23.09 $731,215 - $888,618	-38,485 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$13.53 - $18.17 $520,702 - $699,272	38,485	38,485 $699,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.